关注
Salvatore Carbone, PhD, FHFSA, FASPEN
Salvatore Carbone, PhD, FHFSA, FASPEN
在 vcu.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Sedentary behavior, exercise, and cardiovascular health
CJ Lavie, C Ozemek, S Carbone, PT Katzmarzyk, SN Blair
Circulation research 124 (5), 799-815, 2019
13952019
An overview and update on obesity and the obesity paradox in cardiovascular diseases
A Elagizi, S Kachur, CJ Lavie, S Carbone, A Pandey, FB Ortega, ...
Progress in cardiovascular diseases 61 (2), 142-150, 2018
6592018
Obesity paradox in cardiovascular disease: where do we stand?
S Carbone, JM Canada, HE Billingsley, MS Siddiqui, A Elagizi, CJ Lavie
Vascular Health and Risk Management 15, 89-100, 2019
4152019
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review
MG Del Buono, R Arena, BA Borlaug, S Carbone, JM Canada, ...
Journal of the American College of Cardiology 73 (17), 2209-2225, 2019
319*2019
Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness
S Carbone, MG Del Buono, C Ozemek, CJ Lavie
Progress in cardiovascular diseases 62 (4), 327-333, 2019
3062019
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review
MG Del Buono, RA Montone, M Camilli, S Carbone, J Narula, CJ Lavie, ...
Journal of the American College of Cardiology 78 (13), 1352-1371, 2021
2882021
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin …
O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ...
The lancet Diabetes & endocrinology 5 (11), 887-897, 2017
2762017
Obesity and heart failure: focus on the obesity paradox
S Carbone, CJ Lavie, R Arena
Mayo Clinic Proceedings 92 (2), 266-279, 2017
2752017
Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
S Toldo, C Marchetti, AG Mauro, J Chojnacki, E Mezzaroma, S Carbone, ...
International Journal of Cardiology 209, 215-220, 2016
2002016
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ...
Journal of the American Heart Association 9 (5), e014941, 2020
1942020
Effects of sodium‐glucose cotransporter 2 inhibitors on 24‐hour ambulatory blood pressure: a systematic review and meta‐analysis
WL Baker, LF Buckley, MS Kelly, JD Bucheit, ED Parod, R Brown, ...
Journal of the American Heart Association 6 (5), e005686, 2017
1882017
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
BW Van Tassell, JM Canada, S Carbone, C Trankle, L Buckley, CO Erdle, ...
Circulation: Heart Failure 10 (11), e004373, 2017
1862017
A review of obesity, physical activity, and cardiovascular disease
A Elagizi, S Kachur, S Carbone, CJ Lavie, SN Blair
Current obesity reports 9, 571-581, 2020
1812020
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)
A Abbate, MC Kontos, NA Abouzaki, RD Melchior, C Thomas, ...
The American journal of cardiology 115 (3), 288-292, 2015
1682015
Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse
C Marchetti, S Toldo, J Chojnacki, E Mezzaroma, K Liu, FN Salloum, ...
Journal of cardiovascular pharmacology 66 (1), 1-8, 2015
1632015
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure
LC O’Brien, E Mezzaroma, BW Van Tassell, C Marchetti, S Carbone, ...
Molecular Medicine 20 (1), 221-229, 2014
1622014
Il-1 blockade in patients with heart failure with preserved ejection fraction: Results from dhart2
BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ...
Circulation: Heart Failure 11 (8), e005036, 2018
1522018
Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia
S Carbone, HE Billingsley, P Rodriguez-Miguelez, DL Kirkman, R Garten, ...
Current problems in cardiology 45 (11), 100417, 2020
1392020
Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study
BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, CR Trankle, ...
Journal of cardiovascular pharmacology 67 (6), 544-551, 2016
1262016
Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)
BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ...
Clinical cardiology 40 (9), 626-632, 2017
120*2017
系统目前无法执行此操作,请稍后再试。
文章 1–20